T cell gene therapy - Cell Genesys
Alternative Names: Anti-HIV T cell gene therapyLatest Information Update: 14 Aug 2001
At a glance
- Originator Cell Genesys
- Class Antivirals; Gene therapies
- Mechanism of Action CD4 agonists; CD8 antigen stimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer; HIV-1 infections